EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Methotrexate polyglutamates

Zhilin Yang, Jiayi Mo, Wenshu Li, Zhigang Zhao, Shenghui Mei

Expert Review of Clinical Pharmacology · 2024-11 · 17 (11) · 1025-1037

DOI: 10.1080/17512433.2024.2416674 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 15.10.2024. Verfasst von Zhilin Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China. Hauptthemen laut MEDLINE: Methotrexate, Polyglutamic Acid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: Beijing Municipal Administration of Hospitals, Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Methotrexate polyglutamates (MTXPGs) are intracellular metabolites of methotrexate (MTX) that play a critical role in the drug's activity, influencing both its efficacy and toxicity. As the exact implications of MTXPGs in these processes remain a subject of debate, a comprehensive review of MTXPGs could provide valuable insights for clinicians and pharmacists, potentially minimizing adverse reactions and enhancing therapeutic outcomes. AREAS COVERED: A comprehensive search of relevant literature was conducted in PubMed and Web of Science databases, including studies from their inception to April 2024. Eligible studies included reviews, clinical trials, and real-world analyses. Additional manual searches and citation reviews were also performed. This review aims to explore MTXPGs with a primary focus on their pharmacokinetics, analytical methods, determinants of drug exposure, and their correlation with MTX efficacy and toxicity. EXPERT OPINION: MTXPGs have not yet garnered significant attention in clinical practice. However, multiple studies have demonstrated a relationship between MTXPGs and the efficacy and toxicity of MTX, suggesting a potential avenue for personalized treatment strategies. Future research should aim to further validate and refine this correlation. Additionally, attention should also be directed toward other metabolites of MTX, which may hold clinical significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexatePolyglutamic AcidHumansAnimalsAntirheumatic AgentsPrecision Medicine

Stichwörter der Autor:innen

Analytical methodsefficacymethotrexate polyglutamatespharmacokineticstoxicity

Substanzen

Methotrexatemethotrexate polyglutamatePolyglutamic AcidAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China.
  • Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Beijing, P. R. China.

Förderung

  • Beijing Municipal Administration of Hospitals
  • Capital Medical University

Zitieren

APA

Yang, Z., Mo, J., Li, W., Zhao, Z., & Mei, S. (2024). Methotrexate polyglutamates. Expert Review of Clinical Pharmacology, 17(11), 1025-1037. https://doi.org/10.1080/17512433.2024.2416674

Vancouver

Yang Z, Mo J, Li W, Zhao Z, Mei S. Methotrexate polyglutamates. Expert Review of Clinical Pharmacology. 2024;17(11):1025-1037. doi:10.1080/17512433.2024.2416674

BibTeX
@article{Yang2024,
  author = {Yang, Zhilin and Mo, Jiayi and Li, Wenshu and Zhao, Zhigang and Mei, Shenghui},
  title = {Methotrexate polyglutamates},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2024},
  volume = {17},
  number = {11},
  pages = {1025--1037},
  doi = {10.1080/17512433.2024.2416674}
}
Kostenlos starten →